JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB108914

Human Tissue Type Plasminogen Activator ELISA Kit (TPA)

Be the first to review this product! Submit a review

|

(8 Publications)

Human Tissue Type Plasminogen Activator ELISA Kit (TPA) is a sandwich ELISA designed to quantify Human Tissue Type Plasminogen Activator (TPA) with a sensitivity of 4 pg/mL.

- Colorimetric sandwich ELISA - 450 nm readout - works on any plate reader
- Validated on a number of sample types including cerebrospinal fluid (CSF)
- Wide dynamic range - quantifies 15.625 - 1000 pg/mL

View Alternative Names

Tissue-type plasminogen activator, t-PA, t-plasminogen activator, tPA, PLAT

3 Images
Sandwich ELISA - Human Tissue Type Plasminogen Activator ELISA Kit (TPA) (AB108914)
  • sELISA

Supplier Data

Sandwich ELISA - Human Tissue Type Plasminogen Activator ELISA Kit (TPA) (AB108914)

Representative Standard Curve Using ab108914.

Sandwich ELISA - Human Tissue Type Plasminogen Activator ELISA Kit (TPA) (AB108914)
  • sELISA

Lab

Sandwich ELISA - Human Tissue Type Plasminogen Activator ELISA Kit (TPA) (AB108914)

Tissue Type Plasminogen Activator measured in biological fluids showing quantity (ng) per mL of tested sample. Samples diluted 2-10 fold.

Sandwich ELISA - Human Tissue Type Plasminogen Activator ELISA Kit (TPA) (AB108914)
  • sELISA

Lab

Sandwich ELISA - Human Tissue Type Plasminogen Activator ELISA Kit (TPA) (AB108914)

Tissue Type Plasminogen Activator measured in biological fluids showing quantity (ng) per mL of tested sample. Human samples diluted 3-27 fold. Rat and mouse samples diluted 1-10 fold.

Key facts

Detection method

Colorimetric

Sample types

Cerebral Spinal Fluid, Saliva, Urine, Plasma, Cell culture supernatant, Milk, Serum

Reacts with

Human

Assay type

Sandwich (quantitative)

Sensitivity

>= 4 pg/mL

Range

15.625 - 1000 pg/mL

Assay time

4h

Assay Platform

Microplate

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Reactivity", "Dilution Info", "Notes"] }, "values": { "sELISA": { "reactivity":"TESTED_AND_REACTS", "dilution-info":"", "notes":"<p></p>" } } }

Product details

Human Tissue Type Plasminogen Activator ELISA Kit (TPA) ab108914 is a sandwich ELISA to measure Human Tissue Type Plasminogen Activator (TPA) in serum, plasma, cell culture supernatant, cerebral spinal fluid (CSF), saliva, urine, milk with a sensitivity of 4 pg/ml.

How the assay works

A TPA specific antibody has been precoated onto 96-well plates and blocked. Standards or test samples are added to the wells and subsequently a TPA specific biotinylated detection antibody is added and then followed by washing with wash buffer. Streptavidin-Peroxidase Conjugate is added and unbound conjugates are washed away with wash buffer. TMB is then used to visualize Streptavidin-Peroxidase enzymatic reaction. TMB is catalyzed by Streptavidin-Peroxidase to produce a blue color product that changes into yellow after adding acidic stop solution. The density of yellow coloration is directly proportional to the amount of TPA captured in plate.
The entire kit may be stored at -20°C for long term storage before reconstitution - Avoid repeated freeze-thaw cycles.

Assay Specificity

Our ELISA kits are rigorously validated to ensure the highest level of consistency and reproducibility. Please check the protocol booklet for more details

Human Tissue Type Plasminogen Activator ELISA Kit (TPA) ab108914 protocol summary

1. Add standard or sample to appropriate wells. Incubate at room temperature
2. Wash and add prepared biotin antibody to each well. Incubate at room temperature.
3. Wash and add prepared Streptavidin-Peroxidase Conjugate. Incubate at room temperature
4. Add Chromogen Substrate to each well. Incubate at room temperature
5. Add Stop Solution to each well. Read at 450 nm immediately.

Get results in 90 minutes with our SimpleStep ELISA® kit

Human Tissue Plasminogen Activator ELISA Kit (ab190812)

Precision

[ { "reproducibilityType": "Inter", "sample": "Overall", "replicates": 0, "mean": null, "standardDeviation": null, "coefficientOfVariability": "10.8" }, { "reproducibilityType": "Intra", "sample": "Overall", "replicates": 0, "mean": null, "standardDeviation": null, "coefficientOfVariability": "5.1" } ]

What's included?

{ "values": { "1x96Tests": { "sellingSize": "1 x 96 Tests", "publicAssetCode":"ab108914-1x96Tests", "assetComponentDetails": [ { "size":"2 x 30 mL", "name":"20X Wash Buffer Concentrate", "number":"AB108914-CMP06", "productcode":"" }, { "size":"1 x 120 µL", "name":"50X Biotinylated Human TPA Antibody", "number":"AB108914-CMP10", "productcode":"" }, { "size":"1 x 1 Unit", "name":"TPA Microplate (12 x 8 well strips)", "number":"AB108914-CMP03", "productcode":"" }, { "size":"1 x 30 mL", "name":"10X Diluent N Concentrate", "number":"AB108914-CMP02", "productcode":"" }, { "size":"1 x 11 mL", "name":"Stop Solution", "number":"AB108914-CMP08", "productcode":"" }, { "size":"1 x 80 µL", "name":"100X Streptavidin-Peroxidase Conjugate", "number":"AB108914-CMP09", "productcode":"" }, { "size":"1 x 1 Vial", "name":"TPA Standard", "number":"AB108914-CMP04", "productcode":"" }, { "size":"1 x 7 mL", "name":"Chromogen Substrate", "number":"AB108914-CMP05", "productcode":"" }, { "size":"3 x 1 Unit", "name":"Sealing Tapes", "number":"AB108914-CMP07", "productcode":"" } ] } } }

Properties and storage information

Shipped at conditions
Blue Ice
Appropriate short-term storage conditions
-20°C
Appropriate long-term storage conditions
Multi
Storage information
Please refer to protocols

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

Tissue Plasminogen Activator (tPA) also known as a plasminogen activator acts mechanically to convert plasminogen to plasmin a serine protease. This reaction occurs at the surface of a fibrin clot leading to clot degradation a process known as fibrinolysis. tPA has a molecular mass of approximately 70 kDa. It is mainly expressed in vascular endothelial cells and is released into the bloodstream in response to stimuli such as circulatory stasis or endothelial damage.
Biological function summary

TPA plays a critical role in thrombolysis by breaking down blood clots into their soluble components. It regulates plasminogen function by cleaving this zymogen to yield the active protease plasmin. This function makes tPA integral in maintaining hemostasis and it does not form a part of a larger protein complex. The activity and the regulation of tPA are important for preventing pathologic clotting which can lead to cardiovascular complications.

Pathways

TPA is central to the fibrinolytic pathway. This pathway facilitates the conversion of plasminogen to plasmin enabling clot resolution. In addition tPA interacts with other proteins such as urokinase plasminogen activator (uPA) and inhibitors like plasminogen activator inhibitor-1 (PAI-1). The balance between tPA and its inhibitors is important for the regulation of fibrinolytic activity impacting hemostatic and thrombotic events.

TPA connects closely with conditions like stroke and myocardial infarction due to its thrombolytic properties. In ischemic stroke excessive or insufficient tPA activity can disrupt normal blood flow leading to tissue damage. Additionally in myocardial infarction tPA's role in breaking down clots proves important for restoring coronary blood flow. It is also linked with proteins like fibrinogen as they serve as substrates in the clot degradation process and with PAI-1 which modulates its activity and influences disease progression.

Product protocols

Target data

Converts the abundant, but inactive, zymogen plasminogen to plasmin by hydrolyzing a single Arg-Val bond in plasminogen. By controlling plasmin-mediated proteolysis, it plays an important role in tissue remodeling and degradation, in cell migration and many other physiopathological events. During oocyte activation, plays a role in cortical granule reaction in the zona reaction, which contributes to the block to polyspermy (By similarity).
See full target information PLAT

Publications (8)

Recent publications for all applications. Explore the full list and refine your search

Scientific reports 14:272 PubMed38168649

2024

Comparative analysis of hyperfibrinolysis with activated coagulation between amniotic fluid embolism and severe placental abruption.

Applications

Unspecified application

Species

Unspecified reactive species

Rui Ide,Tomoaki Oda,Yusuke Todo,Kenta Kawai,Masako Matsumoto,Megumi Narumi,Yukiko Kohmura-Kobayashi,Naomi Furuta-Isomura,Chizuko Yaguchi,Toshiyuki Uchida,Kazunao Suzuki,Naohiro Kanayama,Hiroaki Itoh,Naoaki Tamura

Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 29:10760296231179447 PubMed37321605

2023

LncRNA NEAT1 Promotes Vascular Endothelial Cell Dysfunction via miR-218-5p/GAB2 and Serves as a Diagnostic Biomarker for Deep Vein Thrombosis.

Applications

Unspecified application

Species

Unspecified reactive species

Shuping Wang,Fei Wang,Juan Ren,Hongyu Yang

Alzheimer's & dementia : the journal of the Alzheimer's Association 17:605-617 PubMed33226181

2020

Nerve growth factor (NGF) pathway biomarkers in Down syndrome prior to and after the onset of clinical Alzheimer's disease: A paired CSF and plasma study.

Applications

Unspecified application

Species

Unspecified reactive species

Rowan Pentz,M Florencia Iulita,Adriana Ducatenzeiler,Laura Videla,Bessy Benejam,María Carmona‐Iragui,Rafael Blesa,Alberto Lleó,Juan Fortea,A Claudio Cuello

Cell reports 31:107711 PubMed32492423

2020

Assembly and Function of a Bioengineered Human Liver for Transplantation Generated Solely from Induced Pluripotent Stem Cells.

Applications

Unspecified application

Species

Unspecified reactive species

Kazuki Takeishi,Alexandra Collin de l'Hortet,Yang Wang,Kan Handa,Jorge Guzman-Lepe,Kentaro Matsubara,Kazutoyo Morita,Sae Jang,Nils Haep,Rodrigo M Florentino,Fangchao Yuan,Ken Fukumitsu,Kimimasa Tobita,Wendell Sun,Jonathan Franks,Evan R Delgado,Erik M Shapiro,Nicolas A Fraunhoffer,Andrew W Duncan,Hiroshi Yagi,Tomoji Mashimo,Ira J Fox,Alejandro Soto-Gutierrez

Diagnostics (Basel, Switzerland) 10: PubMed32244842

2020

Increased Circulating Levels of Tissue-Type Plasminogen Activator Are Associated with the Risk of Spontaneous Abortion During the First Trimester of Pregnancy.

Applications

Unspecified application

Species

Unspecified reactive species

Lara J Monteiro,Manuel Varas-Godoy,Stephanie Acuña-Gallardo,Paula Correa,Gianluca Passalacqua,Max Monckeberg,Gregory E Rice,Sebastián E Illanes

Animal biotechnology 30:317-322 PubMed30522372

2018

Production of human tissue-type plasminogen activator (htPA) using cultured transgenic pig mammary gland cells.

Applications

Unspecified application

Species

Unspecified reactive species

Hak-Jae Chung,Hyun-Jung Park,Sun-Young Baek,Jin-Ki Park,Won-Young Lee,Kyung-Woon Kim,Yu-Mi Jo,Shinichi Hochi,Yong-Min Kim,Tae-Jeong Choi,Eun-Suek Cho,Kyu-Ho Cho

Journal of stroke and cerebrovascular diseases : t 27:2720-2724 PubMed30037651

2018

Helicopter "Drip and Ship" Flights Do Not Alter the Pharmacological Integrity of rtPA.

Applications

Unspecified application

Species

Unspecified reactive species

Brett A Faine,Sanjana Dayal,Rahul Kumar,Steven R Lentz,Enrique C Leira

Thrombosis research 163:105-116 PubMed29407621

2018

Endothelial cell functions impaired by interferon in vitro: Insights into the molecular mechanism of thrombotic microangiopathy associated with interferon therapy.

Applications

Unspecified application

Species

Unspecified reactive species

Haiyan Jia,Craig Thelwell,Paula Dilger,Chris Bird,Sarah Daniels,Meenu Wadhwa
View all publications
websiteProtocolBooklet
en

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com